Ocular Therapeutix (OCUL) Gross Margin (QoQ) (2014 - 2026)

Ocular Therapeutix (OCUL) Gross Margin (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ocular Therapeutix 1.93 Bn 1.93 Bn 9.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.00
Dec 31, 2025 17.00
Sep 30, 2025 225.00
Jun 30, 2025 -265.00
Mar 31, 2025 -460.00
Dec 31, 2024 292.00
Sep 30, 2024 -94.00
Jun 30, 2024 -20.00
Mar 31, 2024 39.00
Dec 31, 2023 -23.00
Sep 30, 2023 -54.00
Jun 30, 2023 49.00
Mar 31, 2023 -189.00
Dec 31, 2022 178.00
Sep 30, 2022 45.00
Jun 30, 2022 44.00
Mar 31, 2022 -86.00
Dec 31, 2021 178.00
Sep 30, 2021 -143.00
Jun 30, 2021 280.00